Cargando…
Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index
BACKGROUND: CD4+ T lymphocyte (CD4) cell count testing is the standard method for determining eligibility for antiretroviral therapy (ART), but is not widely available in sub-Saharan Africa. Total lymphocyte counts (TLCs) have not proven sufficiently accurate in identifying subjects with low CD4 cou...
Autores principales: | Moore, David M, Awor, Anna, Downing, Robert S, Were, Willy, Solberg, Peter, Tu, David, Chan, Keith, Hogg, Robert S, Mermin, Jonathan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796890/ https://www.ncbi.nlm.nih.gov/pubmed/17233896 http://dx.doi.org/10.1186/1742-6405-4-1 |
Ejemplares similares
-
Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial
por: Mermin, Jonathan, et al.
Publicado: (2011) -
The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy
por: Ekwaru, John P, et al.
Publicado: (2013) -
CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study
por: Kahn, James G, et al.
Publicado: (2011) -
Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings
por: Kiragga, Agnes N, et al.
Publicado: (2010) -
Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings
por: Obirikorang, Christian, et al.
Publicado: (2012)